Membership Directory

Ironwood Pharmaceuticals, Inc.

Category: Drug Development
Phone: (617) 621-8306
Fax: (617) 494-0480
Website: http://www.ironwoodpharma.com
Location: Cambridge, MA

Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood’s GC-C agonist, is an investigational drug for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The efficacy portion of linaclotide’s development program has been completed and supports the submitted NDA submission for both indications, as well as the MAA submission in Europe for the IBS-C indication. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development.

Back to list

Janitronics

AT&T